コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 therefore investigated their suitability to donate blood.
2 ition, which in turn increased intentions to donate blood.
3 tors influence the chemical individuality of donated blood.
4 test exists for screening for B. microti in donated blood.
5 ons taking PrEP to prevent HIV infection are donating blood.
6 ll increases, in percentage terms, of people donating blood.
8 mary cells: (i) myeloid cells generated from donated blood and (ii) well-differentiated airway epithe
9 cohort of 7,054 postmenopausal women who had donated blood and completed questionnaires at a breast c
10 ction of virus-specific assays for screening donated blood and have identified other interventions th
11 ving amprenavir, zidovudine, and lamivudine, donated blood and semen while undergoing treatment, to e
13 presumed latent TB infection (LTBI; n = 38) donated blood and/or bronchoalveolar lavage (BAL) cells
14 donate plasma, 95 were randomly assigned to donate blood, and 95 were randomly assigned to be observ
15 he number of persons with early syphilis who donated blood between 1995 and 2000 in the United States
17 cells (RBCs) are a potential alternative to donated blood, but yield and quality remain a challenge.
18 States, and the movement of blood donors and donated blood components may result in the appearance of
19 o donate plasma every 6 weeks for 12 months, donate blood every 12 weeks for 12 months, or be observe
22 al donation nucleic acid testing (ID-NAT) of donated blood for Zika virus began in U.S. states and te
23 numbers of hemochromatosis patients reported donating blood for therapeutic reasons, our findings sug
24 FOS) of 5 ng/mL or more who were eligible to donate blood, had not donated blood in the 3 months prio
25 esidents of Washington County, Maryland, who donated blood in 1974 (CLUE I) and 1989 (CLUE II), respe
26 e who were eligible to donate blood, had not donated blood in the 3 months prior to randomization, an
27 ndents (4.8%; 95% CI, 3.2% to 6.9%) reported donating blood in 2016 or 2017 and PrEP use within the s
30 ctive adsorption of the causative agent from donated blood might be one of the best ways of managing
33 vivo in humans.MethodsTen healthy volunteers donated blood on the day before receiving the ChAdOx1 nC
34 stored serum samples from persons who either donated blood or were vaccinated with recent seasonal or
35 otherapy and 12 men receiving triple therapy donated blood plasma (BP) and seminal plasma (SP) during
37 singly identified in asymptomatic humans and donated blood samples and is a cause of increased incide
42 at 1% of a given country's population should donate blood to ensure a blood supply that is sufficient
43 ncer, we measured serum levels in 35 men who donated blood to a community-based serum bank in 1974 an
50 hether donors should have been excluded from donating blood, we compared their characteristics with t